Chan, J. A., Ryan, D. P., Zhu, A. X., Abrams, T. A., Wolpin, B. M., Malinowski, P., . . . Kulke, M. H. (2012). Phase I Study of Pasireotide (SOM 230) and Everolimus (RAD001) in Advanced Neuroendocrine Tumors. Endocr Relat Cancer.
Stile di citazione ChicagoChan, Jennifer A., David P. Ryan, Andrew X. Zhu, Thomas A. Abrams, Brian M. Wolpin, Paige Malinowski, Eileen M. Regan, Charles S. Fuchs, e Matthew H. Kulke. "Phase I Study of Pasireotide (SOM 230) and Everolimus (RAD001) in Advanced Neuroendocrine Tumors." Endocr Relat Cancer 2012.
Citazione MLAChan, Jennifer A., et al. "Phase I Study of Pasireotide (SOM 230) and Everolimus (RAD001) in Advanced Neuroendocrine Tumors." Endocr Relat Cancer 2012.
Attenzione: Queste citazioni potrebbero non essere precise al 100%.